Yates v. Pinellas Hematology & Oncology, P.A.
Decision Date | 29 December 2021 |
Docket Number | No. 20-10276,20-10276 |
Citation | Yates v. Pinellas Hematology & Oncology, P.A., 21 F.4th 1288 (11th Cir. 2021) |
Parties | Michele YATES, Plaintiff-Appellee, v. PINELLAS HEMATOLOGY & ONCOLOGY, P.A., Defendant-Appellant, Pratibha Desai, an individual, Defendant. |
Court | U.S. Court of Appeals — Eleventh Circuit |
Christopher David Gray, Scott L. Terry, Florin Gray Bouzas Owens, LLC, Lutz, FL, for Plaintiff-Appellee.
Shyam Dixit, Dixit Law Firm, Edward B. Carlstedt, FordHarrison, LLP, Tampa, FL, for Defendant-Appellant.
Michael Shih, U.S. Department of Justice Civil Division, Appellate Staff, Charles W. Scarborough, U.S. Attorney General's Office, Washington, DC, for Amicus Curiae United States of America.
Before Jordan, Newsom, and Tjoflat, Circuit Judges.
The jury in this qui tam case found that Pinellas Hematology & Oncology violated the False Claims Act, 31 U.S.C. § 3729 et seq., on 214 occasions, and that the United States had sustained $755.54 in damages.Following that verdict, the district court trebled the damages and imposed statutory minimum penalties of $1,177,000 ($5,500 for each of the 214 violations).
On appeal, Pinellas challenges the admission of an exhibit, the jury's verdict on liability and damages, and the monetary award imposed by the district court.After a review of the record, and with the benefit of oral argument, we affirm in part and dismiss in part.
We summarize the facts in the light most favorable to the jury's verdict.SeeRoyal Palm Properties, LLC v. Pink Palm Properties, LLC , 950 F.3d 776, 782(11th Cir.2020).
Pinellas was a medical practice owned by Dr. Pratibha Desai.During the relevant period, Pinellas' headquarters and primary office were located on Park Street in Saint Petersburg, Florida.We refer to this location as Park Place.
Park Place had a clinical laboratory at which, among other things, Pinellas would draw blood from patients and run laboratory tests on those blood samples.For patients who had Medicare coverage, Pinellas would seek reimbursement from the federal government for those tests.
In April of 2015, Pinellas purchased an oncology practice that was located at Bayfront Hospital in Saint Petersburg, Florida.We refer to this practice, which also had its own clinical laboratory, as Bayfront.
Under the Clinical Laboratory Improvement Amendments of 1988 and its regulations, no laboratory can conduct tests on materials derived from the human body unless it has the proper CLIA certificate.See42 U.S.C. § 263a(b);42 C.F.R. §§ 493.1, .3(a), .15, .43–49;Center for Medicare and Medicaid Services, Medicare Claims Processing Manual, § 70.1(2020).Both Park Place and Bayfront had the appropriate CLIA certificates prior to the purchase of Bayfront, but Bayfront's CLIA certificate did not transfer to Pinellas.Because each laboratory location must have its own CLIA certificate, see42 C.F.R. § 493.43(a), Pinellas could not use either of the preexisting CLIA certificates to perform its laboratory tests at Bayfront.Pinellas instead had to obtain a new CLIA certificate for Bayfront linking the latter to it.1
The problem for Pinellas was that it did not have the proper CLIA certificate for Bayfront from April of 2015 until March of 2016, but it still performed tests at Bayfront during that time.The bigger problem for Pinellas was that it then submitted reimbursement claims to Medicare for those tests.And the biggest problem for Pinellas was that when Medicare rejected those claims, it altered the relevant information and resubmitted them—twice.
Michele Yates, Pinellas' billing manager, filed a qui tam action against Pinellas and Dr. Desai.She alleged that they had violated the FCA by defrauding the United States through the submission of the Bayfront reimbursement claims to Medicare and by retaliating against her for attempting to stop their fraudulent conduct.The United States chose not to intervene.See31 U.S.C. § 3730(b)(2).
Before trial, Pinellas filed a motion in limine to exclude Exhibit 24, a spreadsheet prepared by Ms. Yates which summarized some of the allegedly fraudulent claims submitted to Medicare.The district court denied Pinellas' motion without prejudice.
At trial, Ms. Yates told the jury that, between April and July of 2015, Pinellas had billed Medicare over 2,000 times for laboratory tests performed at Bayfront.Because Bayfront did not have a CLIA certificate at that time, those initial claims did not include a CLIA certificate number.As a result, Medicare denied those claims.
To have Medicare pay the claims, Pinellas altered the information on the claim forms to make it seem as if the laboratory tests had been conducted at Park Place, which did have a valid CLIA certificate linked to Pinellas.When it first resubmitted the claims, Pinellas added Park Place's CLIA certificate number to the Bayfront claim forms.Medicare, however, also denied that second set of claims.So, Pinellas resubmitted the claims once again, this time changing the location of service from Bayfront's address to Park Place's address.Medicare paid some of the claims from the third set.
Documentary evidence corroborated Ms. Yates' testimony.For instance, a May 9, 2015, internal email from Lia Valentin, a Pinellas billing assistant, to Ms. Yates and others read as follows:
Michel[e], I just wanted to remind you that the claims with medicare that have labs in them the location has to be switched to pinellas park because the claim are denying until we have the clia fixed for the bayfront office location.Im correcting the claims that came back that did not get paid & refiling them.
Another email sent by Ms. Valentin, on July 14, 2015, stated:
I verify we have not yet added bayfront office ... to Dr. Desai['s] Clia number. the only two offices that are currently ok with the Clia number is park place & largo.For now any denial we receive we change the place of address to Pinellas park address and refile the claim to medicare.[T]hat way we can get the lab paid.
Ms. Yates moved during trial to introduce Exhibit 24—the spreadsheet—into evidence, and Pinellas did not object.She testified that Exhibit 24 showed that Pinellas had submitted 214 claims for Bayfront laboratory tests with Park Place's CLIA certificate number and had changed the location of service to Park Place's address.Out of that total, Medicare paid 64 claims totaling $755.54.2
The jury found Dr. Desai not liable.As to Pinellas, the jury found it liable for having knowingly submitted 214 materially false claims to Medicare, thereby violating the FCA.The jury also found that the United States had suffered $755.54 in damages.
Following the verdict, Pinellas filed a renewed motion for judgment as a matter of law and/or remittitur under Rules 50(b)and59(e) of the Federal Rules of Civil Procedure.In its motion and subsequent filings, Pinellas argued that the evidence presented at trial was insufficient to support the jury's verdict.Pinellas also asserted that, for various reasons, discrete claim subsets should be deducted from the 214 claims for which the jury had found it liable.In the alternative, Pinellas moved for remittitur, submitting that the damages and statutory penalties mandated by the FCA constituted an excessive fine in violation of the Eighth Amendment.
The district court denied Pinellas' renewed motion.It found that the evidence, though contested, was sufficient to support the jury's verdict.As to the damages and statutory penalties, the FCA mandated the imposition of treble damages and statutory penalties of between $5,500 and $11,000 per false claim.See31 U.S.C § 3729(a)(1);28 C.F.R. § 85.3(a)(9).Accordingly, the court imposed a total monetary award of $1,179,266.62—composed of (i) treble damages of $2,266.62 (3 x $755.54), and (ii) the lowest permissible statutory penalty of $1,177,000.00 (214 x $5,500).Though noting that the amount was "very harsh,"the court ultimately held that it did not violate the Eight Amendment's prohibition on excessive fines.SeeD.E. 227at 3–4.
On appeal, Pinellas challenges the district court's admission of Exhibit 24, the jury's verdict on liability and damages, and the total monetary award.We address each argument below.
Pinellas argues that, for various reasons, the district court abused its discretion in admitting Exhibit 24 at trial.Ms. Yates responds that Pinellas failed to preserve its objection, which in any event lacks merit.We agree with Ms. Yates on the first point.
To preserve a claim that a district court improperly admitted evidence, a party must make a timely objection.SeeFed. R. Evid. 103(a)(1)(A).That objection can come before or during trial, and once the district Fed. R. Evid. 103(b).When the objection comes in the form of a motion in limine before trial, a district court makes a definitive ruling if its decision is final or with prejudice; conversely, if the court's ruling is tentative or without prejudice, there is no definitive ruling on the objection.SeeTan Lam v. City of Los Banos , 976 F.3d 986, 1005(9th Cir.2020);1 Jack B. Weinstein & Margaret A. Berger, Weinstein's Federal Evidence, § 103.11[2][b](2d ed. 2021).In the latter scenario, the objecting party must renew its objection at trial to preserve a claim of error for appeal.SeeUnited States v. Wilson , 788 F.3d 1298, 1313(11th Cir.2015);Tan Lam , 976 F.3d at 1006.
When a party fails to preserve an evidentiary objection, we review the district court's admission of evidence for plain error.SeeWilson , 788 F.3d at 1313.To reverse under plain error review, we must find an error that is plain and that has affected the objecting party's substantial rights.SeeUnited States v. Olano , 507 U.S. 725, 733–34, 113 S.Ct. 1770, 123 L.Ed.2d 508(1993);United States v. Hesser , 800 F.3d 1310, 1324(11th Cir.2015)."Once those three conditions have been met,"we...
Get this document and AI-powered insights with a free trial of vLex and Vincent AI
Get Started for FreeStart Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

Start Your 7-day Trial
-
United States ex rel. Zafirov v. Fla. Med. Assocs., LLC
...the Supreme Court sometimes refers to these categories using the umbrella term "qui tam," it does not follow that each is analogous to the FCA, which permits a relator to perform a "traditional, exclusive function of the government."
Yates, 21 F.4th at 1310. For example, consider an ordinary bounty statute offering informers a reward. Such a statute does not authorize the informer to wield power, much less the core executive power a relator exercises by litigating on behalf of theconstitutional norm. The provision permits anyone—wherever situated, however motivated, and however financed—to perform a "traditional, exclusive [state] function" by appointing themselves as the federal government's "avatar in litigation." Yates, 21 F.4th at 1310. That arrangement directly defies the Appointments Clause by permitting unaccountable, unsworn, private actors to exercise core executive power with substantial consequences to members of the public. And although the Supreme Court andsum, by suing on behalf of the United States to secure "essentially punitive" penalties, Stevens, 529 U.S. at 784, 120 S.Ct. 1858, a relator performs a "traditional, exclusive function of the government," Yates v. Pinellas Hematology & Oncology, P.A., 21 F.4th 1288, 1308, 1310 (11th Cir. 2021), that is integral to the "administration and enforcement of the public law," Buckley, 424 U.S. at 139, 96 S.Ct. 612. That kind of core executive power is "significant authority."... -
Race v. Smith
...1288, 1297 (11th Cir. 2021). On the other hand, if the court's ruling is tentative or without prejudice, the court has not ruled "definitively," and "the objecting party must renew its objection at trial to preserve a claim of error for appeal."
Id.In district court proceedings before trial, Race sought to exclude introduction of evidence about Seifried's prior drug use in her motion in limine. The district court denied Race's motion, but that order was not "definitive." The court foundto demonstrate plain error is on the party challenging the evidentiary ruling." Yates, 21 F.4th at 1298. Further, our decision to reverse under plain error review when a party fails to preserve an evidentiary objection is discretionary. Id. at 1297-98; also Fed.R.Evid. 103(e) (noting that "[a] court may take notice of a plain error affecting a substantial right" (emphasis added)). And we have declined to conduct a sua sponte plain error review "when th[e appellant] makes no effortother appropriate sanctions." Fed.R.Civ.P. 37(c)(1). Race waived the issue by failing to object to Dr. Stemer's allegedly improper testimony at trial, after the district court denied her motion in limine as "premature and unripe." See Yates, 21 F.4th at 1297. Contemporaneous objections are particularly important in context because they give the court "a chance to correct [the error] on the spot" by giving the expert a chance to explain apparent inconsistencies in his testimony and the... -
TB Food U.S. LLC v. Am. Mariculture Inc.
...the opposing side that the jury's verdict cannot stand. Yates v. Pinellas Hematology & Oncology, P.A., 21 F.4th 1288, 1298 (11th Cir. 2021). “Stated differently, the verdict will be set aside only if no reasonable jury could have arrived at it.”
Id.Where there is evidence in the trial record that would allow reasonable minds to reach different conclusions, judgment as a matter of law is not appropriate. Mee Indus. v. Dow Chem. Co., 608 F.3d 1202, 1211 (11th Cir. 2010). The Court does24.) Despite the parties' disagreements, the jury's determination was sufficient under the Rule 50(b) standard. There is no evidence that points “‘so overwhelmingly in favor of' [Defendants] that the jury's verdict cannot stand.” Yates, 21 F.4th at 1298. Sufficient Evidence Of Damages Under The DTSA, FUTSA, Or The Lanham Act Defendants argue that TB Food failed to provide sufficient evidence to support any finding of damages under the DTSA, FUTSA, or the Lanham Act. (Doc. #484, p. 21.)... -
Garcia v. Equifax Info. Servs.
...when we view the evidence in the light most favorable to the verdict, we cannot say that the record is insufficient to support the jury's finding that Synovus provided accurate information because it accelerated the account. See
Yates, 21 F.4th at 1298. Gun-ter testified Garcia's loan had been charged off and accelerated. She also testified that the internal reporting system documented the unpaid balance reported as a loss with the full balance past due, which meant the loan had beenYates v. Pinellas Hematology & Oncology, P.A., 21 F.4th 1288, 1298 (11th Cir. 2021). We review the record in the light most favorable to the prevailing party and will set aside the verdict only if no reasonable jury could have arrived at it. Id.And we review denial of a motion for a new trial for abuse of discretion. McGinnis v. Am. Home Mortg. Serv., Inc., 817 F.3d 1241, 1255 (11th Cir. 2016). III. DISCUSSION We divide our discussion into three parts. First, we explain that we do not...
-
False Claims Act Knowledge Element After Schutte: What Is Lost, What Remains, What Companies Should Do Next To Minimize Exposure To Liability
...satisfied because defendant would necessarily know that its reports regarding its number of employed veterans were wrong), rev'd other grounds, 131 S. Ct. 1885 (U.S. 2011). 45. U.S. ex rel. Yates v. Pinellas Hematology & Oncology, P.A.,
21 F.4th 1288, 1303 (11th Cir. 2021) (finding that jury possessed sufficient evidence to find that defendant acted with reckless disregard when testimony indicated that clinical laboratory owner informed buyer that it would need a Clinical Laboratory...
-
Healthcare Law
...Id. (quoting Florida v. Dep't of Health and Hum. Servs., 19 F.4th 1271, 1288 (11th Cir. 2021)).24. Id. at 653.25. Id.26. Id. at 653-54.27. Florida v. Dep't of Health and Hum. Servs., 19 F.4th at 1275.28.
21 F.4th 1288(11th Cir. 2021).29. Id. at 1307. 30. Id. at 1295.31. Id. at 1296.32. Id. at 1307 (quoting 31 U.S.C. § 3730(b)(1) (2010)).33. Id.34. Id.35. Id.36. Id. at 1308-09.37. Id. at 1309.38. Id.39. Id. at 1312-13.40. Id. at 1309-10.41. . Id. at...